This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
Lack of technology transfer stands out as a formidable barrier
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Findings show growing optimism across the pharma sector as dealmaking accelerates, innovation strengthens, and companies adapt to tariffs, pricing reforms, and looming patent expirations
Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography
Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
